Four strains of Butyrivibrio fibrisolvens, transformed with a gene encoding fluoroacetate dehalogenase, maintained a combined population of 10 6 to 10 7 cells ml ؊1 in the rumens of test sheep. Five inoculated sheep showed markedly reduced toxicological symptoms after fluoroacetate poisoning when behavioral, physiological, and histological effects were compared with those of five uninoculated control sheep.
Monofluoroacetate occurs in some Australian plants at levels of up to 5 g kg (dry weight)
Ϫ1 (8) and has a 50% lethal dose in ruminants of around 0.3 mg kg of body weight Ϫ1 (2) . The toxin appears to be cumulative, and a series of sublethal doses can result in fatal poisoning (2) . It is not surprising, therefore, that loss of livestock from fluoroacetate poisoning is economically significant (12) . The work described here is part of a project to develop genetically modified ruminal bacteria that will provide protection against fluoroacetate poisoning.
Three Butyrivibrio fibrisolvens strains, OB156, OB291, and 10/1, were transformed with plasmid pBHf by electroporation (3, 7) and expressed fluoroacetate dehalogenase activity at 10 nmol of fluoride released min Ϫ1 mg of bacterial protein Ϫ1 (7) . Strain OR85 expressed dehalogenase activity at (20 Ϯ 1.7) nmol min Ϫ1 mg Ϫ1 when transformed with a pBHf derivative with four base pairs removed from between the putative Ϫ10 and Ϫ35 regions of the gene promoter (pBHf Ϫ4 ) (unpublished data). OB156, OB291, and OR85 were supplied by R. Forster and R. M. Teather (4) (CFAR, Agriculture and Agrifood Canada, Ottawa, Ontario, Canada). B. fibrisolvens 10/1 was isolated from sheep (11) at the Institute of Biotechnology (University of New England, Armidale, New South Wales, Australia).
Recombinant bacteria were grown in ruminal fluid medium (10) containing yeast extract in place of peptone. Erythromycin was added (50 g ml Ϫ1 ) except in subcultures prepared for inoculation into the rumen. In previous observations (5, 6) , the population of individual bacterial strains within the rumen fluctuated within the range Ͻ10 3 to 10 7 cells ml Ϫ1 . Therefore, a combination of four modified strains was used to ensure that effective numbers of detoxifying bacteria would be present consistently. Fifty-milliliter stationary-phase cultures of each strain (10 8 to 10 9 cells ml Ϫ1 ) were pooled, and 60 ml of the mixture was inoculated into the rumen of each test animal.
Trial I used four Merino/Border-Leicester crossbred sheep, and trial II used six pure-bred Merino sheep; all sheep were housed in metabolism crates in a PC2-classified room. Sheep received four meals daily (150 g of oat chaff plus 50 g of alfalfa chaff) between 10 a.m. and 4 p.m. Water was provided ad libitum.
Sheep rumens were surgically cannulated for removal of samples. These included particles Ͻ1 mm in diameter. Samples were heated (95°C for 10 min) to inactivate nucleases and centrifuged (12,000 ϫ g for 90 s), and the supernatant was removed. The pellet was resuspended in water (10 times the volume of the original sample) and recentrifuged. This procedure was repeated once, and the final pellet was suspended in 10 volumes of water. Dilutions of 10 Ϫ2 , 10
Ϫ3
, 10 Ϫ4 , and 10
Ϫ5
were prepared and tested by PCR for the presence of dehalogenase gene sequences (1). PCR primers used for dehalogenase gene detection were CC5 (5Ј-TGCGAGGCTATGGCGATTCGGACA-3Ј) and CC6.2i (5Ј-CTGACCGATCATGTGCTCGGGGAA-3Ј), both of which amplified a 322-bp fragment from the coding region of the dehalogenase gene (9) . PCR conditions were as follows: 2 cycles of 95°C for 5 min, 55°C for 40 s, and 72°C for 60 s followed by 28 cycles of 95°C for 60 s, 55°C for 40 s, and 72°C for 60 s. Tests on ruminal samples to which transformed bacteria had been added showed that pBHf was detectable in the presence of a single target bacterium. Inclusion of 1 l of sample in the PCR mixture allowed a threshold of detection of 10 3 cells ml 
ml
Ϫ1 in the original sample (Fig. 1) . Preinoculation ruminal samples yielded no dehalogenase gene PCR products and were routinely used as negative controls.
Fluoroacetate solution was injected into snow peas or absorbed into feed pellets or alfalfa biscuits. These were usually eaten voluntarily, even when chaff was refused. The biscuits were Ϸ0.5 g each and were made from alfalfa which had been blended to a coarse slurry with a 10% sucrose solution, pressed into discs to remove most of the fluid, and dried overnight at 60°C. On the three occasions that control sheep 2 (C2) (trial II) refused to eat them, the biscuits were placed into the rumens of both C2 and test sheep 2 (T2) via the cannula. Continuous assessments were made of feeding, drinking, response to external stimuli, stance, movement, and sleeping behavior. In trial II, heart rates were measured with an electrocardiograph.
In trial I, sheep were challenged with fluoroacetate 10 days after inoculation (Table 1) , when the modified strains had established a stable combined population of Ͼ10 7 cells ml Ϫ1 in T1 and Ͼ10 6 cells ml Ϫ1 in T2. In trial II, the recombinant bacteria were allowed five weeks to stabilize their population to Ͼ10 6 cells ml Ϫ1 in all three sheep before challenge with fluoroacetate. Recombinant bacteria were undetectable in control sheep.
Trial I. At a cumulative dose of 0.255 mg of fluoroacetate kg Ϫ1 , control sheep exhibited alarm at familiar noises, compulsive agitated feeding, periodic muscle spasms, "paddling" movements of the legs, skin flushing, panting, and frequent attempts to escape from their crates by jumping. Inoculated test sheep showed occasional head twitching and rapid breathing and periodically increased alertness but remained calm, eating and drinking normally.
At 0.492 mg of fluoroacetate kg Ϫ1 , control sheep showed intensification of all symptoms and died. Behavior of both test sheep remained unchanged. T2 displayed no signs of acute toxicity but, four hours after the death of the control sheep, died of pulmonary edema, which is common in chronic fluoroacetate poisoning (3a). Sheep T1 survived the test. (Table 1) . Heart rates measured for these sheep the day before dosing were in the range of 60 to 80 beats min , control sheep continued to refuse food and remained lethargic, with pronounced unsteadiness when standing. Electrocardiograms showed heart rates rising to 140 to 200 beats min Ϫ1 . Test sheep reduced their feed intake approximately 30% but otherwise behaved normally, with maximum heart rates of 80 to 100 beats min Ϫ1 (T3 only [Fig. 2] ). Prior to administration of fluoroacetate, heart rates of all sheep were in the range of 60 to 80 beats min Ϫ1 . All sheep survived trial II.
Control sheep displayed reduced appetite to day 6, continued unsteadiness on standing up to day 5, and involuntary muscle activity (head twitching) through day 4. T1 and T2 returned to normal eating habits by day 4, and T3 continued to eat approximately 30% less than usual up to day 6. In all other respects, test sheep remained asymptomatic.
Trial II sheep were euthanized with pentobarbitone (Lethobarb), and necropsies were performed by Rob Woodgate and Bruce Chick of the Veterinary Health Research Laboratory, Armidale, New South Wales, Australia. Tissue samples were fixed in 10% formaldehyde for histological examination (S. Hum, Regional Veterinary Laboratory, Menangle, New South Wales, Australia). The control sheep displayed measurably greater tissue damage ( Table 2) .
The intraruminal levels of modified bacteria achieved here allowed us to demonstrate their protective effect upon host animals, but an increased level of protection would be desirable for field trials with larger numbers of animals. This would require additional recombinant strains in the rumen and/or more efficient expression of dehalogenase from each strain. Current work is aimed to achieve these improvements.
